Hepatitis C-associated osteosclerosis (HCAO): report of a new case with involvement of the OPG/RANKL system
- First Online:
- Cite this article as:
- Fiore, C.E., Riccobene, S., Mangiafico, R. et al. Osteoporos Int (2005) 16: 2180. doi:10.1007/s00198-005-1858-8
- 113 Downloads
We report a new case of hepatitis C-associated osteosclerosis (HCAO). The clinical presentation of the patient was an acquired deep severe bone pain with increased serum bone alkaline phosphatase activity (up to 12 times the upper limit of normal), and generalized bone sclerosis, temporally related to the hepatitis C-virus (HCV) infection. We documented in this patient an increase of circulating osteoprotegerin (OPG), and a concentration of circulating receptor activator for nuclear factor-kB ligand (RANKL) below the lower limit of the reference range. The observed abnormalities of the OPG/RANKL system may contribute to the maintenance of the positive balance of bone remodeling that characterizes patients with HCAO.